The Science to Prevail
We are developing disease-modifying gene therapies for patients with Parkinson’s disease and other neurodegenerative disorders.learn more
verb \ pre·vail \ pre-‘vāl
To prove more powerful than opposing forces. To be victorious. To gain ascendance through strength. To triumph. We are developing disease-modifying gene therapies to prevail against neurodegenerative diseases.
June 4, 2019Prevail Therapeutics Announces IND Active for Phase 1/2 Trial of its Gene Therapy PR001 to Treat Parkinson’s Disease Patients with GBA1 Mutations
May 14, 2019Prevail Therapeutics Announces Executive Team Promotion and Appointments to Board of Directors
March 27, 2019Prevail Therapeutics Secures $50 Million in Series B Financing to Advance Pipeline of Gene Therapies for Neurodegenerative Diseases
Prevail Therapeutics is pioneering the development of gene therapies to halt disease progression in patients with Parkinson’s disease and other neurodegenerative and lysosomal disorders.
Leveraging recent breakthroughs in human genetics and transformative successes of AAV-based gene therapy, our goal is to cure diseases caused by lysosomal dysfunction.learn more